Vise Technologies Inc. lifted its position in Genpact Limited (NYSE:G – Free Report) by 237.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,599 shares of the business services provider’s stock after buying an additional 33,475 shares during the quarter. Vise Technologies Inc.’s holdings in Genpact were worth $1,548,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its holdings in Genpact by 12.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,609,641 shares of the business services provider’s stock worth $208,965,000 after acquiring an additional 598,877 shares during the period. First Trust Advisors LP grew its position in shares of Genpact by 10.2% during the 1st quarter. First Trust Advisors LP now owns 2,415,994 shares of the business services provider’s stock valued at $89,996,000 after purchasing an additional 222,899 shares in the last quarter. Temasek Holdings Private Ltd purchased a new position in shares of Genpact during the 1st quarter valued at $30,037,000. Pacer Advisors Inc. increased its holdings in shares of Genpact by 40.7% in the first quarter. Pacer Advisors Inc. now owns 765,204 shares of the business services provider’s stock worth $28,504,000 after purchasing an additional 221,536 shares during the period. Finally, Rice Hall James & Associates LLC increased its holdings in shares of Genpact by 172.5% in the first quarter. Rice Hall James & Associates LLC now owns 704,124 shares of the business services provider’s stock worth $26,229,000 after purchasing an additional 445,743 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Insiders Place Their Bets
In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the firm’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $37.03, for a total value of $229,252.73. Following the sale, the senior vice president owned 70,253 shares of the company’s stock, valued at $2,601,468.59. This trade represents a 8.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.58% of the stock is owned by insiders.
Analyst Ratings Changes
Several research firms recently issued reports on G. Citigroup lifted their price objective on Genpact from $32.00 to $36.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. BMO Capital Markets restated a “market perform” rating and issued a $40.00 target price on shares of Genpact in a research note on Friday, August 7th. Deutsche Bank Aktiengesellschaft set a $31.00 price target on Genpact in a report on Friday, July 10th. Weiss Ratings upgraded Genpact from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, October 14th. Finally, Needham & Company LLC boosted their price objective on Genpact from $45.00 to $55.00 and gave the stock a “buy” rating in a report on Friday. Two investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $41.00.
View Our Latest Analysis on Genpact
Genpact Price Performance
NYSE G traded up $1.14 during trading hours on Friday, reaching $42.24. 3,931,711 shares of the stock traded hands, compared to its average volume of 1,797,965. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.00 and a quick ratio of 2.00. The stock has a 50 day simple moving average of $36.53 and a two-hundred day simple moving average of $35.53. Genpact Limited has a 1 year low of $26.85 and a 1 year high of $48.64. The company has a market cap of $7.06 billion, a price-to-earnings ratio of 12.32, a price-to-earnings-growth ratio of 1.08 and a beta of 0.53.
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The business services provider reported $1.07 EPS for the quarter, beating the consensus estimate of $1.04 by $0.03. Genpact had a return on equity of 23.34% and a net margin of 11.04%. The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.38 billion. During the same period in the prior year, the company earned $0.97 EPS. The company’s revenue was up 7.3% on a year-over-year basis. On average, analysts predict that Genpact Limited will post 3.66 EPS for the current fiscal year.
Genpact Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 23rd. Shareholders of record on Thursday, December 10th will be given a $0.1875 dividend. The ex-dividend date is Thursday, December 10th. This represents a $0.75 annualized dividend and a yield of 1.8%. Genpact’s payout ratio is presently 22.26%.
Key Stories Impacting Genpact
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Genpact reported third-quarter adjusted EPS of $1.07, above estimates of about $1.04–$1.05 and up from $0.97 a year earlier. Revenue increased 7.3% year over year, while ATS revenue grew about 30% and gross margin expanded. Management raised its 2026 gross-margin and adjusted-EPS outlook. G Q3 Earnings Beat Estimates on ATS Growth, Margins Expand
- Positive Sentiment: Needham raised its price target from $45 to $55 and maintained a Buy rating, signaling further potential upside in its view. Needham analyst recommendations
- Neutral Sentiment: Susquehanna lifted its target from $40 to $42 but kept a Neutral rating, indicating a more cautious view than Needham’s. Susquehanna analyst recommendations
- Negative Sentiment: Genpact’s fourth-quarter 2026 revenue guidance of $1.2 billion is below the reported consensus estimate of $1.4 billion, a potential concern that could temper the positive reaction to the quarterly results.
About Genpact
Genpact (NYSE: G) is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.
Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.
Read More
- Five stocks we like better than Genpact
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
